More on EBS
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $8.24 |
|
|||
| Open | $8.24 | ||||
| 52 Wk High | $44.38 | ||||
| 52 Wk Low | $24.47 | ||||
| Day High | $8.24 | ||||
| Day Low | $8.24 | ||||
| P/E | 412.00 | ||||
| EPS | $0.02 | ||||
| Volume | 100 | ||||
- Form 4 Emergent BioSolutions For: Jun 08 Filed by: Williams Paul Anthony
- Form 4 Emergent BioSolutions For: Jun 08 Filed by: LINDAHL RICHARD S
- Form 4 Emergent BioSolutions For: Jun 08 Filed by: Glessner Coleen
- Form 4 Emergent BioSolutions For: Jun 08 Filed by: Hartzel William
- Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
- Benchmark Reiterates Buy Rating on Emergent BioSolutions (EBS)
- Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
- Emergent BioSolutions to Participate in Upcoming Investor Conferences
- Emergent BioSolutions gets Saudi approval for smallpox, mpox vaccine
- Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
Entities mentioned with EBS
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- 13G | View Related Stories »
- Show More...
